Study for Frail Patients With Newly Diagnosed Multiple Myeloma Treated With Daratumumab With Teclistamab or Talquetamab.
Clinical trial NCT07107529 · RECRUITING
Trial details
- NCT number
- NCT07107529
- Sponsor
- European Myeloma Network B.V.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-12
- Primary completion
- 2029-04-01
- Enrollment
- 150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.